What is the appropriate evaluation for an adult with mildly elevated transaminases?

Evaluation of Mildly Elevated Transaminases in Adults

For adults with mildly elevated transaminases (less than 5× upper limit of normal), obtain a targeted history focusing on alcohol use, metabolic risk factors, medications/supplements, and viral hepatitis risk, then perform initial serologic testing including hepatitis B surface antigen, hepatitis C antibody, fasting glucose/lipids, iron studies (iron, TIBC, ferritin), and abdominal ultrasound to identify the most common causes: metabolic dysfunction-associated steatotic liver disease (MASLD) and alcoholic liver disease. 1, 2, 3

Initial Clinical Assessment

The first step is obtaining specific historical information rather than generic evaluation:

• Alcohol consumption: Quantify current and past intake in units per week; consider AUDIT-C screening 1
• Metabolic syndrome features: Central obesity, hypertension, diabetes/insulin resistance, dyslipidemia 1, 2
• Medication review: All prescribed drugs, over-the-counter medications, vitamins, herbal supplements, and illicit drug use 1, 3
• Viral hepatitis risk factors: Country of birth/ethnicity, injection drug use, transfusion history, sexual history 1
• Family history: Liver disease, autoimmune conditions, hereditary disorders 1

Physical examination should document BMI, blood pressure, and signs of chronic liver disease (hepatosplenomegaly, ascites) 1.

First-Line Laboratory Testing

The initial serologic workup should include 1, 2, 3:

• Complete blood count with platelets
• Hepatitis B surface antigen and hepatitis C antibody
• Fasting glucose and lipid profile (to assess for MASLD)
• Iron studies: Serum iron, total iron-binding capacity, ferritin (for hemochromatosis)
• Serum albumin (synthetic function)

Important caveat: Do not simply repeat the same liver enzymes hoping they normalize. Studies show 84% remain abnormal at 1 month and 75% at 2 years 1. The response should be diagnostic evaluation, not observation.

Imaging

Abdominal ultrasound is indicated to exclude bile duct dilatation, focal liver lesions, and assess for hepatic steatosis 4, 1.

Risk Stratification for Fibrosis

If MASLD is suspected based on metabolic risk factors and negative initial workup, calculate the FIB-4 Index (using age, ALT, AST, platelets) or NAFLD Fibrosis Score to identify patients at risk for significant fibrosis who need hepatology referral 5, 2, 3.

Second-Line Testing (If Initial Workup Unrevealing)

Consider additional testing for less common causes 1, 2, 3:

• Autoimmune hepatitis: ANA, smooth muscle antibody, immunoglobulin G levels (particularly if disproportionately elevated transaminases) 6
• Hereditary hemochromatosis: If ferritin elevated, proceed to genetic testing
• Alpha-1 antitrypsin level
• Ceruloplasmin (Wilson disease, especially if age <40)
• Celiac disease serologies (tissue transglutaminase antibody)
• Thyroid function tests
• Creatine kinase (for muscle disorders causing isolated transaminase elevation) 7

Pattern Recognition

The AST/ALT ratio provides diagnostic clues 8:

• AST/ALT >2 suggests alcoholic liver disease (seen in ~70% of cases)
• Ratios >3 are highly suggestive of alcoholic liver disease
• ALT typically exceeds AST in most other chronic hepatitis

Critical threshold: Transaminases >1000 IU/L or ALT >200 IU/L are uncommon in alcoholic hepatitis and should prompt consideration of acute viral hepatitis (A, E, CMV), drug-induced liver injury, or ischemic hepatitis 8, 1.

When to Refer or Biopsy

Referral to hepatology is warranted for 1, 9:

• Persistently elevated transaminases for 6 months or more despite lifestyle modification
• Evidence of synthetic dysfunction (low albumin, prolonged PT)
• Clinical signs of cirrhosis or portal hypertension
• High FIB-4 or NAFLD Fibrosis Score suggesting advanced fibrosis
• Diagnostic uncertainty after complete serologic evaluation

Recent evidence on liver biopsy: In ANA-positive patients with ALT <101 IU/L and no cirrhosis, liver biopsy has limited diagnostic yield (only 9% showed autoimmune hepatitis-compatible histology) and can be safely deferred 10.

Management Principles

All patients should receive counseling on 2, 3:

• Alcohol moderation or cessation
• Weight loss if overweight/obese (target 7-10% body weight reduction for MASLD)
• Avoidance of hepatotoxic medications
• Optimization of metabolic risk factors (diabetes control, lipid management)

Common Pitfalls

• Don't assume normal transaminases exclude significant liver disease: Many patients with cirrhosis or advanced fibrosis have normal ALT/AST 1
• Don't rely on degree of elevation alone: A mildly elevated ALT can represent significant disease depending on etiology 1
• Don't overlook extrahepatic causes: Celiac disease, thyroid disorders, hemolysis, and muscle injury can elevate transaminases 2, 3
• Don't forget drug-induced liver injury: Review ALL medications including supplements—this is a common and reversible cause 1